ARTICLE ONE –
Absolute Truth from the Word of God
From gatewaypundit.com
Stéphane Bancel, CEO of Moderna, announced the development of a new mRNA shot to treat patients suffering from heart failure.
In a statement released on Monday, the pharmaceutical company said it currently has 48 programs in development, including 36 programs that are currently being tested in clinical trials.
These programs include mRNA infectious disease vaccines and mRNA therapeutics that span seven different modalities.
“We enter 2023 in a great position, with significant momentum across our clinical pipeline, a highly energized team and a strong balance sheet of over $18 billion of cash and cash equivalents,” said Stéphane Bancel, Chief Executive Officer of Moderna.
“With our infectious disease franchise continuing to accelerate with exciting near-term catalysts for RSV Phase 3 data and Flu Phase 3 data, and recent breakthroughs in the development of individualized cancer treatments, as well as our rapid advancement in rare diseases and promising cardiology programs, the Moderna platform is delivering across several modalities. Our progress is meeting the high expectations we set out a few years ago, and with encouraging clinical data across the entire Moderna platform, we are accelerating our investments to deliver the greatest possible impact to people through mRNA medicines. Our board has approved a significant increase to our R&D investments, with a budget for 2023 of around $4.5 billion. 2023 is going to be a very exciting year for Moderna, and most importantly, for patients.”
One of the vaccines that the US-based company is working on is the treatment for patients suffering from heart failure….
READ FULL ARTICLE ONE HERE…– Absolute Truth from the Word of God (grandmageri422.me)
ARTICLE TWO –
Risk of heart inflammation higher with Moderna vaccine: study
The risk of developing heart inflammation is two to three times higher with the Moderna COVID-19 vaccine when compared to Pfizer, according to a new Canadian study.
Published in the Journal of the American College of Cardiology, the study found that although cases were rare, men under the age of 40 were the most at-risk of developing heart complications like myocarditis and pericarditis, which usually appeared within 21 days of a second vaccination dose.
Myocarditis refers to inflammation of the heart muscle, while pericarditis is inflammation of the outside lining of the heart.
“Few population-based analyses have been conducted to directly compare the safety of the two mRNA COVID-19 vaccines, which differ in important ways that could impact safety,” the study’s lead author, British Columbia Centre for Disease Control epidemiologist Dr. Naveed Janjua, said in a news release…
READ FULL ARTICLE TWO HERE… | CTV News
Caravan to Midnight
We need your help to keep Caravan to Midnight going,
please consider donating to help keep independent media independent.